Thomas Cech

Thomas Cech
Name	Thomas R. Cech
Birth date	1947-12-08
Birth place	Chicago, Illinois, United States
Nationality	American
Fields	Biochemistry, Molecular Biology
Workplaces	University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado Health Sciences Center
Alma mater	University of Illinois Urbana–Champaign; Massachusetts Institute of Technology
Known for	Discovery of catalytic RNA (ribozymes)
Awards	Nobel Prize in Chemistry, National Medal of Science

Thomas Cech is an American chemist and molecular biologist noted for the discovery that RNA molecules can act as biological catalysts, a finding that revolutionized understanding of RNA world hypothesis, molecular evolution, and gene expression. His work on self-splicing introns and ribozymes contributed to fields spanning biochemistry, genetics, and evolutionary biology. He served in leadership roles at major research institutions and received numerous international awards for his contributions to science.

Early life and education

Cech was born in Chicago and raised in Champaign, Illinois, attending University Laboratory High School (Urbana, Illinois) before earning a B.S. in chemistry at the University of Illinois Urbana–Champaign. He pursued graduate studies at the Massachusetts Institute of Technology under the mentorship of Har Gobind Khorana-linked environments and completed a Ph.D. with research connecting nucleic acids and enzymology. Postdoctoral work took him to the Laboratory of Molecular Biology-adjacent communities and later to faculty positions in Colorado research centers.

Research and scientific contributions

Cech’s laboratory at the University of Colorado Boulder discovered that certain RNA molecules catalyze chemical reactions, demonstrating self-splicing group I introns and defining ribozymes as catalytic RNA. This overturned the prevailing view that only proteins (enzymes) performed catalysis, influencing interpretations of the RNA world hypothesis and hypotheses about the origin of life associated with researchers like Walter Gilbert and Carl Woese. His findings interconnected with studies of transfer RNA, ribosomal RNA, and the catalytic core of the ribosome investigated by groups including Ada Yonath, Venkatraman Ramakrishnan, and Tom Steitz.

Cech’s work employed techniques from site-directed mutagenesis laboratories exemplified by Michael Smith and Francis Crick-era genetics, as well as biochemical assays used in Arthur Kornberg-style nucleotide enzymology. His characterization of self-splicing mechanisms linked to discoveries by Sidney Altman on RNase P and catalysis, and together they shared a Nobel Prize that underscored the emergence of RNA-based catalysis in molecular biology. The implications of his research extended to mRNA splicing pathways characterized by investigators such as Phillip Sharp and Richard Roberts, and to biotechnology applications developed by companies and institutions including Genentech and Biogen.

Cech contributed to understanding RNA structure-function relationships through collaborations and interactions with structural biology groups at institutions like the European Molecular Biology Laboratory and the Max Planck Society, and intersected conceptually with computational biology advances from researchers at Los Alamos National Laboratory and Cold Spring Harbor Laboratory.

Academic career and leadership

Cech joined the faculty of the University of Colorado Boulder and the University of Colorado Health Sciences Center, where he directed a research program that trained students and postdoctoral fellows who later joined faculties at institutions such as Harvard University, Massachusetts Institute of Technology, Stanford University, Johns Hopkins University, and University of California, San Francisco. He served as president of the Howard Hughes Medical Institute, participating in national science policy dialogues involving agencies like the National Institutes of Health and the National Science Foundation. His administrative tenure involved interactions with professional societies including the National Academy of Sciences, the American Academy of Arts and Sciences, and the Royal Society.

Cech held visiting appointments and delivered lectures at universities and research centers worldwide, collaborating with colleagues at University of Cambridge, University of Oxford, ETH Zurich, University of Tokyo, and Peking University. His leadership extended to editorial roles and advisory positions for funding bodies and philanthropic organizations such as the Gordon and Betty Moore Foundation.

Awards and honors

Cech received the Nobel Prize in Chemistry (shared with Sidney Altman), the National Medal of Science, the Heineken Prize, and memberships in the National Academy of Sciences, the Institute of Medicine (now the National Academy of Medicine), and the American Philosophical Society. He was awarded honorary degrees and honors from institutions including Harvard University, Yale University, University of Cambridge, ETH Zurich, and Imperial College London. Other recognitions include the Gairdner Foundation International Award and the Louisa Gross Horwitz Prize.

Personal life and legacy

Cech’s scientific legacy is reflected in the transformation of research on nucleic acids, the training of generations of scientists who joined faculties at institutions such as Princeton University, Columbia University, University of Chicago, and Duke University, and the influence of ribozyme concepts on therapeutic approaches explored by biotech companies and clinical researchers at centers like Mayo Clinic and Memorial Sloan Kettering Cancer Center. He has been involved in public communication on science issues including funding and research integrity in forums alongside leaders from the Howard Hughes Medical Institute and the National Academies. His honors and institutional leadership continue to shape priorities in molecular biology research and education.

Category:Nobel laureates in Chemistry Category:American biochemists Category:University of Colorado faculty